Literature DB >> 23109100

Functional interaction between calsequestrin and ryanodine receptor in the heart.

Marta Gaburjakova1, Naresh C Bal, Jana Gaburjakova, Muthu Periasamy.   

Abstract

Evidence obtained in the last two decades indicates that calsequestrin (CSQ2), as the major Ca(2+)-binding protein in the sarcoplasmic reticulum of cardiac myocytes, communicates changes in the luminal Ca(2+) concentration to the cardiac ryanodine receptor (RYR2) channel. This review summarizes the major aspects in the interaction between CSQ2 and the RYR2 channel. The single channel properties of RYR2 channels, discussed here in the context of structural changes in CSQ2 after Ca(2+) binding, are particularly important. We focus on five important questions concerning: (1) the method for reliable detection of CSQ2 on the reconstituted RYR2 channel complex; (2) the power of the procedure to strip CSQ2 from the RYR2 channel complex; (3) structural changes in CSQ2 upon binding of Ca(2+) which cause CSQ2 dissociation; (4) the potential role of CSQ2-independent regulation of the RYR2 activity by luminal Ca(2+); and (5) the vizualization of CSQ2 dissociation from the RYR2 channel complex on the single channel level. We discuss the potential sources of the conflicting experimental results which may aid detailed understanding of the CSQ2 regulatory role. Although we mainly focus on the cardiac isoform of the proteins, some aspects of more extensive work carried out on the skeletal isoform are also discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109100     DOI: 10.1007/s00018-012-1199-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  81 in total

Review 1.  Luminal Ca(2+) activation of cardiac ryanodine receptors by luminal and cytoplasmic domains.

Authors:  Derek R Laver
Journal:  Eur Biophys J       Date:  2009-03-03       Impact factor: 1.733

2.  Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum.

Authors:  S Wang; W R Trumble; H Liao; C R Wesson; A K Dunker; C H Kang
Journal:  Nat Struct Biol       Date:  1998-06

3.  Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin.

Authors:  R D Mitchell; H K Simmerman; L R Jones
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

4.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

5.  Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Alex V Postma; Isabelle Denjoy; Theo M Hoorntje; Jean-Marc Lupoglazoff; Antoine Da Costa; Pascale Sebillon; Marcel M A M Mannens; Arthur A M Wilde; Pascale Guicheney
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

6.  Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.

Authors:  Dmitry Terentyev; Alessandra Nori; Massimo Santoro; Serge Viatchenko-Karpinski; Zuzana Kubalova; Inna Gyorke; Radmila Terentyeva; Srikanth Vedamoorthyrao; Nico A Blom; Giorgia Valle; Carlo Napolitano; Simon C Williams; Pompeo Volpe; Silvia G Priori; Sandor Gyorke
Journal:  Circ Res       Date:  2006-04-06       Impact factor: 17.367

7.  Effect of Zn2+ ions on ryanodine binding to sarcoplasmic reticulum of striated muscles in the presence of pyrithione.

Authors:  Hong Xie; Ke-ying Chen; Pei-hong Zhu
Journal:  Acta Pharmacol Sin       Date:  2004-12       Impact factor: 6.150

8.  Regulation of the gating of the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel by luminal Ca2+.

Authors:  R Sitsapesan; A J Williams
Journal:  J Membr Biol       Date:  1994-02       Impact factor: 1.843

9.  The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering.

Authors:  Anuradha Kalyanasundaram; Naresh C Bal; Clara Franzini-Armstrong; Björn C Knollmann; Muthu Periasamy
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

10.  Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins.

Authors:  Pierre Tijskens; Larry R Jones; Clara Franzini-Armstrong
Journal:  J Mol Cell Cardiol       Date:  2003-08       Impact factor: 5.000

View more
  17 in total

1.  Multisite phosphorylation of the cardiac ryanodine receptor: a random or coordinated event?

Authors:  Jana Gaburjakova; Eva Krejciova; Marta Gaburjakova
Journal:  Pflugers Arch       Date:  2020-10-19       Impact factor: 3.657

2.  Identification of calcium binding sites on calsequestrin 1 and their implications for polymerization.

Authors:  Amit Kumar; Harapriya Chakravarty; Naresh C Bal; Tuniki Balaraju; Nivedita Jena; Gauri Misra; Chandralata Bal; Enrico Pieroni; Muthu Periasamy; Ashoke Sharon
Journal:  Mol Biosyst       Date:  2013-04-29

3.  The C-terminal calcium-sensitive disordered motifs regulate isoform-specific polymerization characteristics of calsequestrin.

Authors:  Naresh C Bal; Nivedita Jena; Harapriya Chakravarty; Amit Kumar; Mei Chi; Tuniki Balaraju; Sharad V Rawale; Jayashree S Rawale; Ashoke Sharon; Muthu Periasamy
Journal:  Biopolymers       Date:  2015-01       Impact factor: 2.505

4.  Catecholaminergic Polymorphic Ventricular Tachycardia - Looking to the Future.

Authors:  Andreea Elena Velcea; Calin Siliste; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2017-12

5.  Two pools of IRE1α in cardiac and skeletal muscle cells.

Authors:  Qian Wang; Jody Groenendyk; Tautvydas Paskevicius; Wenying Qin; Kaylen C Kor; Yingjie Liu; Florian Hiess; Bjorn C Knollmann; S R Wayne Chen; Jingfeng Tang; Xing-Zhen Chen; Luis B Agellon; Marek Michalak
Journal:  FASEB J       Date:  2019-05-03       Impact factor: 5.834

6.  Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.

Authors:  Atara Novak; Lili Barad; Avraham Lorber; Mihaela Gherghiceanu; Irina Reiter; Binyamin Eisen; Liron Eldor; Joseph Itskovitz-Eldor; Michael Eldar; Michael Arad; Ofer Binah
Journal:  J Cell Mol Med       Date:  2015-07-08       Impact factor: 5.310

7.  Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions.

Authors:  Haiyan Chen; Giorgia Valle; Sandra Furlan; Alma Nani; Sandor Gyorke; Michael Fill; Pompeo Volpe
Journal:  J Gen Physiol       Date:  2013-07-15       Impact factor: 4.086

8.  The Concise Guide to PHARMACOLOGY 2013/14: ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 9.  Calsequestrin, a key protein in striated muscle health and disease.

Authors:  Daniela Rossi; Alessandra Gamberucci; Enrico Pierantozzi; Caterina Amato; Loredana Migliore; Vincenzo Sorrentino
Journal:  J Muscle Res Cell Motil       Date:  2020-06-02       Impact factor: 2.698

10.  Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Zhen Tan; Zhichao Xiao; Jinhong Wei; Jingqun Zhang; Qiang Zhou; Chris D Smith; Alma Nani; Guogen Wu; Long-Sheng Song; Thomas G Back; Michael Fill; S R Wayne Chen
Journal:  Biochem J       Date:  2016-09-13       Impact factor: 3.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.